新聞Ranbaxy sold assets to Myrevital on May 9th '15.At issue is a facility Sun bought eight years ago from Ranbaxy Laboratories, which was a poster child for lax manufacturing standards in India.
新聞Dinesh Thakur leaves Ranbaxy.The central character of the story is Dinesh Thakur, a pharma executive who leaves Ranbaxy after learning about the fraud and becomes a whistleblower.
